|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication April 10, 2006.
Revised June 8, 2006.
Accepted for publication June 20, 2006.
/
and DNA Methylation
Human Organic Anion Transporter 3 (hOAT3/SLC22A8) is predominantly expressed in the proximal tubules of the kidney, and plays a major role in the urinary excretion of a variety of organic anions. The promoter region of hOAT3 was characterized to elucidate the mechanism underlying the tissue specific expression of hOAT3. The minimal promoter of hOAT3 was identified to be located approximately 300 bp upstream of the transcriptional start site, where there are canonical TATA and HNF1 binding motifs, which are conserved in the rodent Oat3 genes. Transactivation assays revealed that HNF1
and HNF1
markedly increased hOAT3 promoter activity, where the transactivation potency of HNF1
was lower than that of HNF1
. Mutations in the HNF1 binding motif prevented the transactivation. Electrophoretic mobility shift assays demonstrated binding of the HNF1
/HNF1
homodimer or HNF1
/HNF1
heterodimer to the hOAT3 promoter. It was also demonstrated that the promoter activity of hOAT3 is repressed by DNA methylation. Moreover, the expression of hOAT3 was activated de novo by forced expression of HNF1
alone or both HNF1
and HNF1
together with the concomitant DNA demethylation in HEK293 cells that lack expression of endogenous HNF1
and HNF1
, whereas forced expression of HNF1
alone could not activate the expression of hOAT3. This suggests a synergistic action of the HNF1
/HNF1
homodimer or HNF1
/HNF1
heterodimer and DNA demethylation for the constitutive expression of hOAT3. These results indicate that the tissue specific expression of hOAT3 might be regulated by the concerted effect of genetic (HNF1
and HNF1
) and epigenetic (DNA methylation) factors.
Key words:
Promoter analysis, Organic anion, Regulation - transcriptional
This article has been cited by other articles:
![]() |
S.-Y. Ahn and S. K. Nigam Toward a Systems Level Understanding of Organic Anion and Other Multispecific Drug Transporters: A Remote Sensing and Signaling Hypothesis Mol. Pharmacol., September 1, 2009; 76(3): 481 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adalat, A. S. Woolf, K. A. Johnstone, A. Wirsing, L. W. Harries, D. A. Long, R. C. Hennekam, S. E. Ledermann, L. Rees, W. van't Hoff, et al. HNF1B Mutations Associate with Hypomagnesemia and Renal Magnesium Wasting J. Am. Soc. Nephrol., May 1, 2009; 20(5): 1123 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Yee, J. E. Shima, S. Hesselson, L. Nguyen, S. De Val, R. J. LaFond, M. Kawamoto, S. J. Johns, D. Stryke, P.-Y. Kwok, et al. Identification and Characterization of Proximal Promoter Polymorphisms in the Human Concentrative Nucleoside Transporter 2 (SLC28A2) J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 699 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Imai, R. Kikuchi, H. Kusuhara, S. Yagi, K. Shiota, and Y. Sugiyama Analysis of DNA Methylation and Histone Modification Profiles of Liver-Specific Transporters Mol. Pharmacol., March 1, 2009; 75(3): 568 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saji, R. Kikuchi, H. Kusuhara, I. Kim, F. J. Gonzalez, and Y. Sugiyama Transcriptional Regulation of Human and Mouse Organic Anion Transporter 1 by Hepatocyte Nuclear Factor 1 {alpha}/{beta} J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 784 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kikuchi, H. Kusuhara, N. Hattori, I. Kim, K. Shiota, F. J. Gonzalez, and Y. Sugiyama Regulation of Tissue-Specific Expression of the Human and Mouse Urate Transporter 1 Gene by Hepatocyte Nuclear Factor 1 {alpha}/beta and DNA Methylation Mol. Pharmacol., December 1, 2007; 72(6): 1619 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ogasawara, T. Terada, J.-i. Asaka, T. Katsura, and K.-i. Inui Hepatocyte nuclear factor-4{alpha} regulates the human organic anion transporter 1 gene in the kidney Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1819 - F1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Asaka, T. Terada, K. Ogasawara, T. Katsura, and K.-i. Inui Characterization of the Basal Promoter Element of Human Organic Cation Transporter 2 Gene J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 684 - 689. [Abstract] [Full Text] [PDF] |
||||